Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Novozymes Will Close Hyaluronic Acid Plant

January 14, 2008 | A version of this story appeared in Volume 86, Issue 2

Novozymes is closing a plant in Shandong province, China, that produces hyaluronic acid via Streptococcus bacteria fermentation. The plant employs 132 people. Novozymes bought the plant in 2006 to complement its existing Bacillus-based production but subsequently encountered price erosion in the dietary supplement market and a low-growth outlook in the technical market. Novozymes says it will continue to develop its Bacillus products for high-end applications such as eye drops, drug delivery, and tissue engineering.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.